ORPHA:50817
Duane anomaly-myopathy-scoliosis syndrome
Also known as: Verloes-Deprez syndrome
Is anyone studying this?
135
135 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.
135 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).
117 in the last 10 years · high confidence · 70.2th percentile (publications denominator)
Is a treatment being tested?
0
trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 26 July 2026
No matched interventional trials. This is true for 59.2% of diseases in the trials denominator (151 of 255). Here are the researchers publishing on it.
high confidence · 29.6th percentile (trials denominator)
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Who's working on it?
894
Distinct author names in 135 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Kuhlmann E5 papers · 2023
Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, OE 6830, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. kuhlmann.ellen@mh-hannover.de.
Papers in Europe PMC - 02Dopfer-Jablonka A3 papers · 2022
Clinic for Rheumatology and Immunology, Hannover Medical School, Hanover, Germany.
Papers in Europe PMC - 03Nikčević AV3 papers · 2022
Department of Psychology, School of Law, Social and Behavioural Sciences, Kingston University, Kingston, UK.
Papers in Europe PMC - 04Spada MM3 papers · 2022
School of Applied Sciences, London South Bank University, London, UK.
Papers in Europe PMC - 05Abidin NEZ2 papers · 2024
Faculty of Sports and Exercise Science, University of Malaya, Kuala Lumpur, Malaysia.
Papers in Europe PMC - 06Aviles Gonzalez CI2 papers · 2025
Department of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, Italy.
Papers in Europe PMC - 07Behrens GMN2 papers · 2022
Clinic for Rheumatology and Immunology, Hannover Medical School, Hanover, Germany.
Papers in Europe PMC - 08Blain B2 papers · 2019
Motivation, Brain and Behavior Team, Centre de NeuroImagerie de Recherche, Institut du Cerveau et de la Moelle épinière, Hôpital de la Pitié-Salpêtrière, 75013 Paris, France; INSERM UMRS 1127, CNRS UMR 7225, Université Pierre et Marie Curie-Paris 6, 75005 Paris, France; Centre d'Economie de la Sorbonne, Université Paris 1, 75013 Paris, France.
Papers in Europe PMC - 09Boamah SA2 papers · 2023
School of Nursing, 62703McMaster University Faculty of Health Sciences, Hamilton, ON, Canada.
Papers in Europe PMC - 10Cai Y2 papers · 2024
Department of Physical Education, Sun Yat-Sen University, Guangzhou, China. caiym@mail.sysu.edu.cn.
Papers in Europe PMC
Recruiting interventional trials
Trials testing a treatment from the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it above — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.
"Duane anomaly-myopathy-scoliosis syndrome" OR "Verloes-Deprez syndrome"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Duane anomaly-myopathy-scoliosis syndrome" OR "Verloes-Deprez syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
0Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus